Ta strona została przetłumaczona automatycznie i dokładność tłumaczenia nie jest gwarantowana. Proszę odnieść się do angielska wersja za tekst źródłowy.

TransThoracic Ultrasound for Descending Aortic Aneurysms (THORUS)

3 sierpnia 2026 zaktualizowane przez: Imperial College London

Feasibility, Accuracy and Reproducibility of Ultrasound in Aneurysms of the Descending Thoracic Aorta

The goal of this observational study is to assess the applicability of non-invasive ultrasound in aneurysms of the descending thoracic aorta.

The main question it aims to answer is:

What is the feasibility of Ultrasound to visualise the Descending Thoracic Aorta, and can this imaging modality accurately measure the maximum size of aneurysms and residual sacs with acceptable reproducibility?

Participants are having their diagnosis confirmed or excluded by conventional imaging techniques (CT scans). Participants receive exactly the same standard of care regardless of their participation. The study offers an additional ultrasound scan, and the results will be compared with previous imaging.

Przegląd badań

Status

Jeszcze nie rekrutacja

Warunki

Szczegółowy opis

Aneurysms of the aortic artery are a significant public health issue. The number of newly diagnosed aneurysms of the thoracic aorta is on the rise, and aneurysm rupture is a catastrophic event associated with high mortality rates. The most proximal sections of the aorta (ascending and the aortic arch) are routinely scanned by echocardiography practitioners. The abdominal aorta is also easily visualised on transabdominal ultrasound, and there is a screening programme in the UK that is highly cost-effective and reduced the aneurysm-related number of deaths. However, the portion of the aorta in the chest (descending thoracic aorta) is not routinely assessed by ultrasound practitioners.

The diagnosis of descending thoracic aneurysms relies mostly on imaging techniques that use ionising radiation. In addition, these techniques are expensive and may not be widely available in some regions. In contrast, ultrasound is a non-invasive technique that allows visualisation of most parts of the body. Ultrasound machine suppliers have invested in better systems and transducers over the years and visualisation of the descending thoracic aorta may now be possible.

The main aims of this study are to assess the feasibility (Part 1), accuracy (Part 2) and reproducibility (Part 3) ultrasound in the diagnosis and monitoring of descending thoracic aortic aneurysms. Participants will be recruited from the vascular lab and outpatient clinics, and diameters of the descending thoracic aorta will be measured with non-invasive ultrasound. Data obtained from study measurements will be compared with computed tomography scans that patients had as part of their standard of care.

If the feasibility, accuracy and reproducibility of Ultrasound are clearly demonstrated, routine ultrasound scans of the descending thoracic aorta may be suggested.

Typ studiów

Obserwacyjny

Zapisy (Szacowany)

Kontakty i lokalizacje

Ta sekcja zawiera dane kontaktowe osób prowadzących badanie oraz informacje o tym, gdzie badanie jest przeprowadzane.

Kontakt w sprawie studiów

Nazwa: Carlos Pinho, PhD Student
Numer telefonu: +44 20 3312 3374
E-mail: cv1026@ic.ac.uk

Kopia zapasowa kontaktu do badania

Nazwa: Cheuk Fund Wong
Numer telefonu: +44 20 7594 9832
E-mail: rgit@imperial.ac.uk

Lokalizacje studiów

Zjednoczone Królestwo
- London
  - London, London, Zjednoczone Królestwo, W2 1NY
    - Imperial College Healthcare NHS Trust - St Mary's Hospital
    - Kontakt:
      
      Carlos Pinho, PhD Student
      
      Numer telefonu: +44 20 3312 3374
      
      E-mail: cv1026@ic.ac.uk
    - Kontakt:
      
      Cheuk Fund Wong
      
      Numer telefonu: +44 20 7594 9832
      
      E-mail: rgit@imperial.ac.uk
    - Główny śledczy:
      
      Carlos Pinho, PhD Student

Kryteria uczestnictwa

Badacze szukają osób, które pasują do określonego opisu, zwanego kryteriami kwalifikacyjnymi. Niektóre przykłady tych kryteriów to ogólny stan zdrowia danej osoby lub wcześniejsze leczenie.

Kryteria kwalifikacji

Wiek uprawniający do nauki

Dorosły
Starszy dorosły

Akceptuje zdrowych ochotników

Tak

Metoda próbkowania

Próbka bez prawdopodobieństwa

Badana populacja

All Participants will receive a single Ultrasound scan as part of this study. All Patients had at least one CT scan of the thoracic aorta prior to the study as part of their standard of care. No additional radiation or invasive imaging techniques will be used in the Thorus study. The data obtained from the CT will be analysed by an independent reviewer and compared with Ultrasound measurements. Participants will be recruited prospectively from a single NHS Trust in London - Imperial College Healthcare NHS Trust.

Opis

Inclusion Criteria:

Patients with diagnosed AAA or other vascular condition attending the vascular scanning department for routine ultrasound and confirmed healthy DTA (Control group).
Patients with known DTAA (including Type B dissection) or patients who had TEVAR previously (Case group).
Patients who have had CT as part of their standard of care.
Patients able to tolerate the scan (Lying in supine position).
Adults aged 18 or over.
Willing to provide consent.

Exclusion Criteria:

Patient under 18 years of age.
Previous thoracic surgery or body deformity (severe kyphosis, scoliosis, pleural effusion or chest wall trauma).
Patients without previous imaging of the thoracic aorta.
Life expectancy <2 years.
Pregnant Women.
Patients unwilling to provide consent or unable to comply with study requirements.
Patients too frail to travel to routine outpatient appointments.
Inability to attend the appointment due to time constraints or other commitments.
Although rare, ultrasound contraindications as described in the scanning protocol are also exclusion criteria.

Plan studiów

Ta sekcja zawiera szczegółowe informacje na temat planu badania, w tym sposób zaprojektowania badania i jego pomiary.

Jak projektuje się badanie?

Szczegóły projektu

Liczba grup / kohort

Kohorty i interwencje

Grupa / Kohorta
CONTROLS Patients with healthy DTA (30 patients)
CASES Patients with DTAA or TEVAR (30 patients)

Co mierzy badanie?

Podstawowe miary wyniku

Miara wyniku	Opis środka	Ramy czasowe
Part 1 - Feasibility - Proportion of participants with successful ultrasound measurement of the diameter of the descending thoracic aorta Ramy czasowe: Day 1 - At the single ultrasound study visit.	Number and percentage of participants in whom the descending thoracic aortic diameter can be obtained by transthoracic ultrasound. The units of Measure are total number and percentages.	Day 1 - At the single ultrasound study visit.
Part 1 - Feasibility - Length of the descending thoracic aorta by Ultrasound Ramy czasowe: Day 1 - At the single ultrasound study visit.	Total length of the descending thoracic aorta from the aortic isthmus to the coeliac axis. The unit of Measure is Centimetres (cms).	Day 1 - At the single ultrasound study visit.
Part 1 - Feasibility - Ultrasound Quality Score Ramy czasowe: Day 1 - At the single ultrasound study visit.	Number of ultrasound windows that allow visualisation of the descending thoracic aorta (0 to 3 windows) and allocation of a quality score. The Unit of Measure is a score created for this study (0-Windows: No views; 1 window: Poor; 2 windows: Moderate; 3 windows: Good). Higher scores mean better image quality.	Day 1 - At the single ultrasound study visit.
Part 2 - Accuracy - Comparision between Transthoracic Ultrasound and CT Ramy czasowe: Day 1 - At the single ultrasound study visit.	Calculate mean differences and limits of agreement between TUS and CT. Achieve high sensitivity and specificity.	Day 1 - At the single ultrasound study visit.
Part 3 - Reproducibility - Intraclass correlation coefficient Ramy czasowe: Day 1 - At the single ultrasound study visit.	Calculate inter- and intra-operator variability by intraclass correlation coefficient (ICC). The study aims to achieve good or excellent reliability.	Day 1 - At the single ultrasound study visit.

Miary wyników drugorzędnych

Miara wyniku	Opis środka	Ramy czasowe
Part 1 - Feasibility - Factors limiting visualisation of the Descending Thoracic Aorta Ramy czasowe: Day 1 - At the single ultrasound study visit.	Number and percentages of participants in whom limiting factors such as body habitus or rib shadowing are reported after the ultrasound test. The units of measure are the number of participants with raised BMI (kg/m^2) and acoustic shadowing due to bone density.	Day 1 - At the single ultrasound study visit.
Part 1 - Feasibility - Duration of Ultrasound Examination Ramy czasowe: Day 1 - At the single ultrasound study visit.	Total time needed to complete the ultrasound scan of the descending thoracic aorta. The unit of measure is minutes.	Day 1 - At the single ultrasound study visit.
Part 1 - Feasibility - Patient Feedback Questionnaire Ramy czasowe: Day 1 - At the single ultrasound study visit.	Scores are obtained from the patient feedback questionnaire that was created specifically for this study and consists of 5 questions relating to comfort, tolerability and overall experience of the ultrasound scan. The unit of measure is a score ranging from 1-Strongly Disagree to 5-Strongly Agree. Higher scores mean better patient satisfaction.	Day 1 - At the single ultrasound study visit.

Współpracownicy i badacze

Tutaj znajdziesz osoby i organizacje zaangażowane w to badanie.

Sponsor

Imperial College London

Śledczy

Krzesło do nauki: Professor Colin Bicknell, Imperial College London

Daty zapisu na studia

Daty te śledzą postęp w przesyłaniu rekordów badań i podsumowań wyników do ClinicalTrials.gov. Zapisy badań i zgłoszone wyniki są przeglądane przez National Library of Medicine (NLM), aby upewnić się, że spełniają określone standardy kontroli jakości, zanim zostaną opublikowane na publicznej stronie internetowej.

Główne daty studiów

Rozpoczęcie studiów (Szacowany)

7 września 2026

Zakończenie podstawowe (Szacowany)

5 kwietnia 2027

Ukończenie studiów (Szacowany)

3 kwietnia 2028

Daty rejestracji na studia

Pierwszy przesłany

28 lipca 2026

Pierwszy przesłany, który spełnia kryteria kontroli jakości

3 sierpnia 2026

Pierwszy wysłany (Rzeczywisty)

7 sierpnia 2026

Aktualizacje rekordów badań

Ostatnia wysłana aktualizacja (Rzeczywisty)